Table 2

Published studies of MSCs in CIA.

Author, Year

MSC

Route

Cell number

Day of delivery

Outcome


Djouad, 2005

C3H10T1/2

iv

106

0

-

106

21

-

4 × 106

0

-

4 × 106

21

Exacerbation

Augello, 2007

BM C57/Bl/10 or

GFP transgenic

ip

5 × 106

21

Amelioration

Choi, 2008

BM DBA/1

iv

106

21, 28, 35

Delayed onset

Gonzalez, 2009

hAdMSC

Ad DBA/1

Ad C57/Bl6

ip

106

5 days after disease onset

Amelioration

Schurgers, 2010

BM DBA/1 WT or

IFNγ KO

iv or ip

106

1, 16, 23

-


Ad, adipose derived; BM, bone marrow derived; h, human; ip, intraperitoneal; iv, intravenous; KO, knock out; WT, wild type.

Sullivan et al. Arthritis Research & Therapy 2012 14:R167   doi:10.1186/ar3916

Open Data